Elaros is a private digital health company incubated by NHS organisations, that represents a breakthrough, not only in terms of the innovative nature of its product development, but also in its partnership approach that brings together the NHS, the academic community and industry.
The NHS organisations involved in ELAROS are:
Devices for Dignity: a NIHR Healthcare Technology Co-operative set up to
drive forward innovative new products, processes and services to support people with long-term conditions, preserving their dignity and independence.
Devices for Dignity is hosted by Sheffield Teaching Hospitals NHS Foundation Trust.
Medipex Ltd and NHS Innovations North:
the UK NHS Innovation Hubs for Yorkshire & Humber and the North East Region. Their mission is to facilitate the development of services and products that cut costs and improve patient care.
Sheffield Teaching Hospital NHS Foundation Trust: who provide the clinical direction for ELAROS.
North Tyneside Clinical Commissioning Group: with whom Elaros is working to commercialiase the hydration monitoring system, Hydr8.
Elaros is a private digital health company incubated by NHS organisations, that adopts a partnership approach to product development, bringing together the NHS, the academic community and industry to develop solutions that are:
Elaros includes among its partners, the following organisations:
C19-YRS is an outcome measure used to screen for common persistent symptoms identified in patients after contracting COVID-19, also known as Long COVID. The self-reporting tool has been developed by clinical academics at The University of Leeds and has been recommended for routine use by NHS England in their National Guidance for post-COVID syndrome assessment and has been recognised by NICE in their rapid guidelines for managing the long-term effects of COVID-19. More details of the benefits offered by C19-YRS can be viewed through the product brochure accessible here, as well as through its dedicated website at www.c19-yrs.com.
Long COVID is a term used to describe a new and emerging condition faced by patients presenting with symptoms that develop during or after contracting COVID-19 and persist for more than 4 weeks (NICE). The syndrome is still not yet fully understood, with symptoms of breathlessness, cough and severe fatigue being amongst the most prevalent symptoms. As of January 24th 2021 the World Health Organisation estimates there have 97.4 million confirmed cases of COVID-19, with the Office of National Statistics estimating that:
ELAROS’ C19-YRS boasts a secure web portal for clinicians to manage patients over time, through visualisation of the graded scores for Symptom Severity, Functional Disability and Overall Health, helping to guide and evaluate treatment and rehabilitation programmes.
Patients can access the user-friendly questionnaire via web-link or mobile app, available on iOS and Android, allowing them to track their condition with a quantitative assessment of improvement or deterioration. The platform seeks to improve patient outcomes, clinical intervention methods and help to understand Long COVID as a condition by providing The University of Leeds’ research team with anonymised data to further validate the scale and develop a robust measure of the condition.
The system provides a secure, scalable solution to manage multiple patients on a single platform and is free at the point of use for all NHS organisations.
The C19-YRS captures data automatically and generates a report to clinicians in real time, offering powerful reporting tools to both clinicians and patients.
For more information, please contact firstname.lastname@example.org
Your Data Privacy
Partners and endorsements
ELAROS’ C19-YRS was rapidly developed to a high standard, by working closely with clinical researchers at University of Leeds and Pipe & Piper Ltd to pivot ELAROS’ existing CE-marked Digital Bladder Diary platform. The paper C19-YRS self-report is being slowly adopted by NHS Trusts across the UK as of December 2020. ELAROS’ digital C19-YRS aims to improve the Long COVID patient care pathway and offer patients and clinicians an enhanced, secure, remote digital alternative solution.
C19-YRS was developed with support from The University of Leeds, Leeds Teaching Hospitals NHS Trust, Leeds Community Healthcare NHS Trust, Airedale and Hull NHS Trusts.
Recommended for routine use by NHS England in their National Guidance for post-COVID syndrome assessment and has been recognised by NICE in their rapid guidelines for managing the long-term effects of COVID-19 as a clinically relevant tool, requesting further validation and development with patients and clinicians.
At some point in their life two out of every three adults will have a bladder related problem, requiring a visit to their GP to identify the problem. Currently, people presenting to their GP with bladder problems are required to complete a paper diary that is then returned to their GP for analysis.
The Digital Bladder Diary replaces the paper diary with a hand held recording device that enables people to monitor their own health safely and discreetly.
The process of recording information is simple, and enables the patient to take control and management of their bladder issues with dignity. The device is discreet and convenient and the information captured is 100% secure. Using the device enables the patient to keep an accurate up to date bladder diary wherever they are. More details of the Digital Bladder Diary can be accessed here.
The information gathered using the diary is uploaded remotely to the cloud which provides an immediate clinical diagnosis and recommended clinical action.
Use of the device ensures accurate clinical analysis of data resulting in greatly reduced clinical referrals and unnecessary hospital visits. The time taken to diagnose and treat a patient's symptoms is cut, reducing anxiety for the patient and offering quick relief from symptoms.
This innovative new way of carrying out initial assessment, diagnosis and triaging of patients with long-term conditions has been specifically designed to be integrated into GP practices, specialist continence providers, community health organisations and acute trusts. The service enhances delivery of the patient pathway and enables compliance with NICE guidelines.
The Digital Bladder diary was developed in collaboration with urology experts from Sheffield Teaching Hospitals NHS Foundation Trust, with support from the Yorkshire and Humber Academic Health Science Network and the North East & North Cumbria Academic Health Science Network.
Dehydration in older people is among the top 10 reasons for hospital admission resulting in a significant financial impact on the healthcare system. Yet dehydration in older people can easily be prevented or treated with an appropriate hydration programme.
Hydr8 is a platform by which care homes can monitor the fluid intake of their residents. Each resident has their own profile on the Hydr8 app, where their fluid intake is recorded. The cumulative total can be viewed at a glance, with an infographic displaying the percentage of hydration status attained. Residents at risk of becoming under, or over, hydrated can easily be identified and a standardised protocol then guides staff to the appropriate response. Data from all residents is relayed back to a central data store which is accessible to the care home manager, care home provider, CCG and authorised clinicians.
Hydr8 was developed by North Tyneside Clinical Commissioning Group and Nine Software company Ltd, with support from the Academic Health Science Network, North East and North Cumbria.
Sleep is essential for human survival. Lack of adequate sleep leads to many detrimental health effects.
Common behavioural sleep problems include difficulties falling asleep, an inability to maintain sleep and early morning awakenings.
Evidence has shown that paediatric behavioural sleep programmes improve sleep duration in children and thus have a positive impact on the whole family. Using the Sleepy Fox app, carers are taught to understand the science behind sleep and to create a personalised bedtime plan along with strategies to help the child get a good night's sleep.
Partners and funding
Sleepy Fox was developed in collaboration with the Children's Sleep Charity and Sheffield Children's Hospital NHS Foundation Trust, supported by funding from the SBRI.
Dysphagia is a condition that affects the ability to swallow and affects many elderly people, including residents in care homes.
The swallowing mechanism changes significantly as people age and its disruption can have long-range health consequences in older adults, including dehydration and malnutrition.
The Guide is intended to be a one-stop shop for care home staff from caterers and care home assistants to care home managers and care home policy makers. It includes essential information about dysphagia, recipes suitable for residents with swallowing difficulties and specialist training modules for catering staff. It is accessible on Android or iOS tablets.
Partners and funding
The Guide was developed in collaboration with Luto, Making Sense Ltd and experts in dysphagia from Sheffield Teaching Hospitals NHS Foundation Trust, supported by funding from Innovate UK and the Abbeyfield Research Foundation.
Professor Paul O' Brien was appointed CEO of Elaros 24/7 in April 2012. Paul has held senior posts in the private sector (Chief Executive), local government (Chief Officer), health (Director in West Essex NHS Trust) and education (Head of Department).
He has previous venture start-up experience having established the Essex Development and Regeneration Agency with a turnover of £8.5 million and funds under management of £15 million - employing 60 planners, economists, surveyors, bid writers and fund managers.
He has extensive experience of public sector transformation having externalised a local government service and more recently the externalisation of a £33 Million NHS Service.
Paul also has broad non-executive board experience gained over a 15 year period and has completed the Institute of Directors Diploma in Company Direction.
He is a visiting lecturer to the University of Surrey on its MBA & MSc Entrepreneurship programmes.
Professor Christopher Chapple is a Consultant Urological Surgeon at Sheffield Teaching Hospitals and Visiting Professor at Sheffield Hallam University. He has a particular interest in functional reconstruction of the lower urinary tract and the underlying pharmacological control mechanisms and provides a tertiary service in lower urinary tract reconstructive surgery. He trained at the Middlesex Hospital where he subsequently completed his doctorate thesis, and continued there and at the Institute of Urology in London for his sub-specialist training.
He is Chairman of the International Relations Committee at the European Association of Urology, having previously been the Adjunct Secretary General responsible for Education and Past Director of the European School of Urology. He is editor-in-chief of the journal Neurourology and Urodynamics and is on the editorial board of several journals such as the British Journal of Urology, European Urology, Surgery and Current Opinion in Urology. He is an active member of many international urological associations and societies including the British Association of Urological Surgeons, the European Association of Urology, the International Continence Society, the Association of Academic European Urologists and the American Association of Genitourinary Surgeons. He has chaired a number of guidelines initiatives including the NICE Guidelines Development Group on male lower urinary tract symptoms. He was awarded the St Peter’s medal by the British Association of Urological Surgeons in 2011. Professor Chapple has co-authored over 350 articles in peer-reviewed Journals and has written several books and a number of book chapters.
Peter Cunliffe qualified as a Chartered Accountant in 1983, having trained in Birmingham with one of the then ‘Big 4’ accountancy firms, Deloitte Haskins and Sells.
Since qualifying, Peter has worked in various finance and accounting roles for a wide spectrum of businesses, both in terms of size (£3m up to £1.2bn turnover) and industry sector (including retail, engineering, steel stockholding, laboratory analysis and specialty chemicals).
His early positions were in large blue-chip companies, roles which gave him a full understanding of the importance of pertinent, current management information and the need for strict financial disciplines to augment performance and safeguard assets.
Recognising that most small companies do not need a full-time financial director, Peter set up Flex FD Ltd in 2004, providing a flexible financial direction service for start-up and early-stage companies, particularly in the life science and healthcare sectors, and has helped raise £7m in funding across 10 businesses.
Román Rocha Lawrence first joined Elaros in July 2019 as our Graduate Trainee Research & Development Manager after graduating from The University of Sheffield with a First Class Honours MEng Degree in Bioengineering.
As part of his degree which drew on various engineering disciplines, management, science and medicine, Román specialised in Biomaterials, Tissue Engineering, Medical Devices and Computational Medicine; completing a summer research project with INSIGNEO in 2018; Europe’s largest research institute dedicated entirely to the development, validation, and use of in silico medicine technologies.
Román made a substantial impact at Elaros in his first year using his broad depth of knowledge of interdisciplinary STEM subjects and entrepreneurial experience outside of academia, forming key partnerships for the company at an early stage and managing various internal and Innovate UK funded projects and consultancy contracts.
Moving forward as Elaros’ Research and Development Manager, Román leads on the development, management and commercialisation of Elaros’ various projects and product portfolio whilst managing the growing internal team.
Gabriel joined Elaros in October 2020, as a graduate with First Class Honours in BSc Information Technology Management for Business at the University of Sheffield. Gabriel's degree looked at the combination of management and computing and how essential an effective understanding of these are in the modern workplace. His dissertation project focused on usability and User Experience Design (UX).
After a successful Year in Industry working as an IT Applications Engineer, Gabriel is now looking to develop the skills acquired through his four year course with his new Graduate Trainee Technology Manager role at Elaros. With the global transition into digital and remote working that has been catalysed by the coronavirus pandemic, Gabriel's work with our products and partners to ensure we provide usable and secure applications is sure to be extremely valuable.
(28th May, 2021). People with long covid could be monitored with the aid of a ground-breaking mobile phone app and clinical web portal.
It has been developed to help NHS rehabilitation teams manage the large number of people suffering from the debilitating effects of the illness. Patients will also be able to use the app to track their recovery.
The app will initially be available to patients in 27 NHS Trusts, including the Salford Royal, Pennine Acute Hospitals, Liverpool University Hospitals, Airedale and Leeds Community Healthcare NHS Trusts - and the app provider is in advance discussion with several others. The public will not have direct access to the app - instead, patients will be invited to download it by their doctor or a member of their rehabilitation team.
Developed in a partnership between the University of Leeds, Leeds Teaching Hospitals and Leeds Community Healthcare NHS Trusts, and the digital health company ELAROS, with the support from their software developers, Pipe and Piper, the app will enable patients to self-report their symptoms and the impact they have on daily living.
The first hospitals to use the system will go live with it next week (June 1).
‘Long covid’ refers to persistent symptoms that last for four weeks or longer after contracting covid-19, and include breathlessness, fatigue, brain fog, psychological distress, pain, and a general decline in quality of life.
Figures from the Office of National Statistics have revealed that during four weeks in February and March, more than one million people in the UK were experiencing long covid - 674,000 said the condition was adversely affecting their day-to-day activities. Of those, around 697,000 people had experienced symptoms for at least 12 weeks.
Approximately, 70,000 had been ill for a year.
The information that a patient puts onto the app will be stored on a secure and confidential database which can be accessed by the NHS team involved in their care, to monitor their progress and to evaluate treatment options.
Dr Manoj Sivan, Associate Professor in the School of Medicine at the University of Leeds and Consultant in Rehabilitation Medicine at Leeds Teaching Hospital and Community Healthcare NHS trusts, is the lead academic in the project.
He said: “Long covid is a new condition, and it is causing long-term health problems for many patients. Given the scale of the problem, it is likely to strain healthcare services and burden the economy. We need efficient systems to manage the growing caseload and to standardise care across the NHS.
“The app and associated web portal will allow healthcare staff to rapidly assess and triage patients. Patients and families can also see their progression and their response to treatments."
The app takes the patient through a series of questions to record their health status before contracting covid, and what it is now. The information is displayed in two radar plots: one showing the severity of symptoms and how those symptoms may be impacting on their ability to perform daily activities, their level of functional disability.
Patients will be asked to regularly update the app and over time, the radar plots will show what progress they are making towards recovering their health.
Jenny Davison, Physiotherapist and Long Covid Rehabilitation Service Coordinator with Leeds Community Healthcare Trust, said: "A Patient will be able to update the app at different stages in their recovery – and it will show them and their clinician how they are improving and what areas might need more targeted input.
“It provides an excellent visual demonstration of the data in graph format for patient to see at a glance the improvements they have made."
Professor Paul O’Brien, Chief Executive of ELAROS, said: “The digital nature of the system will allow us to rapidly improve the clinical tool in partnership with healthcare professionals as we learn more about the condition. Our aim is to help healthcare teams provide the most effective support for patients recovering from long covid."
“This is a not-for-profit initiative for all NHS organisations as part of ELAROS' contribution to the national effort to tackle Covid”.
The app uses a version of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS), a questionnaire developed by Dr Sivan and his team during the first wave of the pandemic to aid the diagnosis and assessment of long covid symptoms.
C19-YRS is now widely used across the NHS and has been recommended for routine use by NHS England in their national guidance for post-covid syndrome assessment clinics. Guidelines from the National Institute of Health and Care Excellence also support its use for comprehensive assessment of patients.
If a patient agrees, their responses recorded on the app can be shared with accredited research institutions, but personal details will be removed.
For healthcare organisations wishing to utilise the digital version, please contact: email@example.com
For more information on the digital system, visit www.c19-yrs.com
(17th August, 2020). ELAROS is pleased to announce that the company will be hosting a University of Sheffield student for the next two weeks as part of our company's summer placement programme.
Oscar Petherick is a final-year Bioengineering Masters Degree Student at The University of Sheffield, specialising in Tissue Engineering and Biomaterials. We first met Oscar whilst delivering our annual lecture at the university to third-year bioengineering students.
ELAROS colleagues are looking forward to welcoming Oscar on board.
(31st July, 2020). ELAROS is pleased to announce the appointment of Gabriel L Clarkson as the company's Graduate Trainee Technology Development Manager.
Gabriel has just graduated from The University of Sheffield with a First Class BSc Honours Degree in Information Technology Management for Business with a year in industry at Siemens Industrial Turbomachinery Ltd.
Gabriel joins the ELAROS Graduate Trainee Programme through funding provided by Santander Bank under its SME Internship Programme.
The ELAROS Team is looking forward to welcoming Gabriel on board on the 14 September 2020.
(21st July, 2020). Health Education England e-Learning for Healthcare (HEE e-LfH) has worked in partnership with Sheffield Teaching Hospitals NHS Foundation Trust, Royal College of Speech and Language Therapists and industry experts to develop the Dysphagia Guide e-learning resource for those working with people living with dysphagia.
Elaros is proud to have collaborated with colleagues and experts at Sheffield Teaching Hospital with support from Abbeyfield Research Foundation and Innovate UK on the initial project that has now been developed by Health Education England to roll out the platform nationwide.
Dysphagia, which is difficulties chewing and/or swallowing food and drinks, has serious implications for a person’s health and wellbeing with increased likelihood of chest infections, malnutrition, dehydration, choking incidents and hospitalisations.
The resource, which was co-developed with care home staff and is relevant to others in the health and care workforce, informal carers and people with dysphagia themselves, can be used to support people working in care to gain the relevant level of competency for their role as outlined in the Eating, Drinking and Swallowing Competency Framework. This resource is also a useful guide for managers in policy and workforce development.
The Dysphagia Guide e-learning resource, which has been adapted by HEE e-LfH, is made up of five sessions that cover the following topics:
For more information about the e-learning resource, including access details, please visit: https://www.e-lfh.org.uk/programmes/dysphagia/.
SHEFFIELD (1st July, 2020). ELAROS is pleased to announce the appointment of Román Rocha Lawrence to the post of Research & Development Manager which he will begin at the company on the 1st of August 2020.
Román joined ELAROS in July 2019, through a 12-week Santander SME funded Programme, having graduated from the University of Sheffield with a First Class Honours in his Bioengineering (MEng) degree. Following the completion of his internship, Román was offered a full-time place onto ELAROS’s intensive Graduate Trainee Management Scheme.
Román has now passed through the graduate programme and made a real and significant impact on the company, including, initiating an important new academic relationship.
In his new role, Román will manage, mentor and support ELAROS’s newest colleague - our Graduate Trainee Technology Manager - who will join the company through the Santander SME Programme on the 14 September 2020. This new colleague will be announced on the 31 July 2020.
SHEFFIELD (10th December, 2019). Elaros has been working with colleagues at London South Bank University for three years on very exciting applications of a technology (currently operating outside of the health/care sectors) that we believe will have a transformational impact upon; healthcare, care, self-management and the broader and growing consumer space of well-being.
ELAROS is delighted that this work has ‘pivoted’ into health and through LSB University we have been able to build a global partnership of like-minded thinkers and organisations (academic, health, commercial and governmental).
Significant funding to launch this work in Brussels in January 2020 has been secured.
We will create:
RELIABLE TECHNOLOGIES AND MODELS FOR VERIFIED WIRELESS BODY-CENTRIC TRANSMISSION AND LOCALIZATION.The partnership involves universities from Finland, Norway, Italy, the UK and two other private companies from Italy.
The partnership also involves universities from; Australia, Japan, Thailand and the USA (two) as well as The National Institute of Standards and Technology, a non-regulatory agency of the United States Department of Commerce.
Leeds (6th December, 2019). Elaros CEO, Professor Paul O'Brien, is delighted to have been asked by Grow MedTech to be one of the 'Dragons' in the Pump Prime Funding Competition pitches, that will take place in the afternoon session of the Conference in Leeds on the 6 December 2019.
The four pitches include:1. SMILE – A novel diagnostic for depression Presenters: Sareen Galbraith and Mukundan Chetan Satyajit
SHEFFIELD (November, 2019). We are pleased to have Elaros CEO, Professor Paul O'Brien, invited to the 2019 National Care Forum (NCF) Conference to demonstrate a range of Elaros' care home products, namely: the Digital Bladder Diary, Hydr8 and Sleepy Fox.
We will be meeting care home managers during the day and showing them how our various products improve resident care, reduce costs and free up carer time to spend with residents
SHEFFIELD (23rd August, 2019). Elaros is pleased to share an important paper published on the 15th of August regarding another product that Elaros is collaborating on for the care home sector, this time with Sheffield Teaching Hospital's NHS Foundation Trust.
The product development was funded by the UK Government through Innovate UK/The Design Council and funding made available from the Abbeyfield Research Foundation.
The paper entitled: "The Development of a Digital Dysphagia Guide with Care Homes: Co-Production and Evaluation of a Nutrition Support Tool" can be found at: https://lnkd.in/gTDbK6m.
Over the coming year, ELAROS will use the approach that it has developed to digitalise this guide to develop guides in other clinical areas with the company's 11 UK university partners and clinical teams in a number of NHS Teaching Hospitals.
LONDON (16th August, 2019). Elaros is pleased to have its CEO, Paul O'Brien, invited to present at the second National Hydration Network Conference in London tomorrow on the 17th of September, 2019.
The presentation will focus on the implementation of our hydration management and monitoring app for care homes (Hydr8) and its further developments planned for beyond its launch later this year.
Sheffeld (11th August, 2019). Elaros is pleased to kick-off an Innovate UK project today to further the development of our innovative Digital Bladder Diary; a hand-held device designed to help the growing number of men and women in the UK that suffer from bladder problems.
This project will place the bladder diary in specialist continence clinics and GP practices to compare the use of the diary with current practice, paper-based diaries. ‘Real-world’ data will be collected which will help to fully evaluate the clinical and health economic impact of the diary.
This funding will enable Elaros and its partners, to carry out the work that will enable the final adoption of the diary into clinical practice, which will reduce the unnecessary, inappropriate and very costly referrals to hospitals from GPs. The diary is registered as a Class 1 medical device and has been evaluated by NICE.
We are looking forward to working with our partners, Glasgow Caledonian University and the York Health Economic Forum on the project over the coming year.
SHEFFIELD (2nd August, 2019). Elaros is pleased to announce that Dr. Clare Williamson has joined Elaros as Programme Manager with an initial focus on delivering Elaros’ recently awarded Innovate UK Project.
Graduating from King’s College, London, with a BSc (Hons) in Pharmacology & Toxicology, she moved to Sheffield in 1999 where she completed her PhD studies at Sheffield Hallam University, investigating the role of antibodies in patients with gluten ataxia. Clare then worked on gluten ataxia as a post-doctoral researcher during which time she was a co-author on several research papers and presented her work at various scientific conferences.
Clare then joined the NIHR: Y&H Clinical Research Network where she worked with a small team of research nurses across South Yorkshire carrying out clinical trials on diabetes. Most recently, Clare has been passing on her enthusiasm for science as a secondary school science teacher.
Clare will enable Elaros and its partners (the University of York and Glasgow Caledonian University) to complete the Innovate UK project in order to provide the evidence that NICE has requested to undertake a Medical Technologies Evaluation Programme of Elaros' Digital Bladder Diary.
SHEFFIELD (5th August, 2019). We here at Elaros are delighted that our former colleague, Dr Angel Jimenez-Aranda (now Digital Technology Lead at Devices for Dignity), was announced as Highly Commended in the Digital Health Awards ‘Future Digital Leader of the Year 2019’ category.
Angel is a true pioneer and certainly a future leader to watch.
SHEFFIELD (28th July, 2019). Elaros is pleased to appoint Román Rocha Lawrence as our new Graduate Trainee Research & Development Manager. He will manage a number of Elaros projects and support the development of Elaros' R&D portfolio.
Román has just graduated from The University of Sheffield with a First Class Honours Degree in Bioengineering (MEng) and will join the Elaros Team tomorrow (Monday the 29 July 2019). As part of his degree he specialised in Biomaterials, Tissue Engineering and Computational Medicine; completing a summer research project with Insigneo in 2018.
Román has a broad depth of knowledge in interdisciplinary STEM subjects and experience working in high pressure environments in both academia and the workplace. Over the past 3 years he has developed a strong business acumen through organising and promoting his own events in the Yorkshire region; managing others, building professional relationships and marketing.
The team is looking forward to welcoming him on board.
SHEFFIELD (29th July, 2019). Elaros is pleased to welcome MSc student in Software Systems & Internet Technology at The University of Sheffield, Qidi Wu, to the team for the summer.
Qidi is undertaking his summer assignment with Elaros as part of an agreement with the University of Sheffield. Qidi is focused on reviewing/ probing the security arrangements around a number of Elaros' emerging products and providing an external eye.
Elaros looks forward to developing the relationship beyond Qidi's studies in the UK and exploring opportunities to collaborate with organisations in Qidi's home city in China, Cangzhou.
SHEFFIELD (22nd July, 2019). Elaros has secured grant funding from Santander bank to part-fund a graduate trainee research & development manager role. The funding is provided through Santander Bank's SME programme that is managed by The University of Sheffield.
Our new Graduate Trainee R&D Manager will be starting at Elaros on Monday the 29th of July.
(3rd July, 2019). Elaros has signed a partnership deal with The University of Huddersfield and UScale to produce a measurement device to benefit LUTS sufferers. The project was brought together by the University’s Dr Luke Watson who is also a Technology Innovation Manager for Grow MedTech, which provides specialist support for innovation in medical technologies and who are funding this project.
One of the main obstacles to successful treatment is the availability of a straightforward test to measure how severely the patient is being affected. Currently, patients are asked to use jugs to measure the amount of urine they pass for three consecutive days and record the results in a paper-based diary. This can feel undignified and leads to low compliance. The lack of information provided to health professionals as a result affects the quality of treatment they’re able to provide.
Elaros, UScale and The University of Huddersfield are combining two separate technologies to address the problem. UScale, developed by Dr James Williamson at the University of Huddersfield and NHS urologist Nicolas Bryan, provides a more effective way of taking measurements, while a digital bladder diary devised by Elaros helps maintain an accurate, easily accessible record. Using UScale, the patient urinates into a disposable container connected to a digital scale. The device records the weight, and the patient can simply empty the receptacle and throw it in the bin before leaving the bathroom
Meanwhile, the digital bladder diary developed by Elaros enables users to track the volume, urgency and frequency that they urinate over the three-day monitoring period, using a smartphone app. The data captured is analysed by a powerful algorithm, linked to NICE Guidelines, before providing an indicative diagnosis back to the health professional. The data and report can then be added directly into the patient record.
These two technologies will be brought together into one prototype device using a £20,000 Proof of Feasibility grant from Grow MedTech. The combined device will enable UScale to automatically complete an online digital bladder diary when used and make this information accessible by the patients’ health professional.
The Grow MedTech Technology Innovation Manager who brokered the new partnership, Dr Luke Watson, says: “In isolation each party’s device improves patient compliance, but when combined they create an all-in-one solution with the potential to improve treatments for millions.”
Dr James Williamson said: “Currently patients tend only to record measurements at home because of the impracticality of taking a measuring jug to work. This new device will require minimal training and, because it’s small and discrete, it can be used in a public toilet or at work without risk of embarrassment.”
Elaros’ CEO Professor Paul O’ Brien said: “We know the significant role that academic collaborations play in advancing our work. This collaboration allows us to further our goal of developing a powerful diagnostic tool to support clinicians in providing effective treatments and provides a dignified healthcare solution for end-users.”
Dr James Williamson said: “Currently patients tend only to record measurements at home because of the impracticality of taking a measuring jug to work. This new device will require minimal training and, because it’s small and discrete, it can be used in a public toilet or at work without risk of embarrassment.” Lead clinical partner and urologist Dr Nicolas Bryan said: “This funding is helping us to develop a product that will be widely useful and will help patients secure the right treatment to allow them to achieve the best outcome.”
(20th June, 2019). The University of West London (UWL) signs new partnership deal with Elaros to digitise its hydration management tool, I-Hydrate, for care homes.
More than 400,000 people live in care homes in the UK and residents are vulnerable to the effects of dehydration, such as confusion, falls and infection. Dehydration can easily be prevented and yet is one of the top 10 common reasons for elderly people being admitted to hospital - costing the NHS over £1bn every year.
I-Hydrate was developed by two UWL academics, Alison Tingle and Professor Jennie Wilson, for use in care homes in order to improve hydration. The toolkit will be incorporated Elaros’ popular hydration management app, Hydr8. The app allows care home staff to monitor the fluid intake of residents so those at risk of hydration can be identified and action taken to prevent ill-health.
Professor Anthony Woodman, Deputy Vice-Chancellor and Provost for Health at UWL, said: “Our I-Hydrate toolkit is already being used by care homes across the country to improve the health of older people. By partnering with Elaros to digitise the toolkit we will be able to have an even greater positive impact on our society.”
Elaros CEO, Professor Paul O’Brien, added: “Our work is all about collaborating with professionals in the industry to develop digital technologies to deliver better healthcare solutions. By working with UWL we can help to deliver simple and effective solutions that can transform the health of residents in care homes.”
Find out more about UWL's I-Hydrate project.
SHEFFIELD (24th April, 2019). Elaros has signed a strategic partnership deal with Arquella Limited; a Sheffield-based company that has built a successful business delivering nurse call systems and falls prevention equipment to care homes. By pairing Arquella’s understanding of the care home sector with Elaros’ expertise in digital health products, the two companies hope to expand their reach into the care home market.
Reuben Timoney, Director of Arquella, said: “This partnership will help both companies achieve their goals of building excellent products for the care home market, by expanding the range of products each is currently able to offer.” He added, “Arquella will be launching a new product platform that will be able to incorporate Elaros’ existing digital care home products, thereby expanding our portfolio”.
Elaros CEO, Professor Paul O’Brien, added: “Through this partnership both companies hope to advance the uptake of technology in care homes. Arquella gain access to the products that we are developing and Elaros gains access to an established customer base”.
Care homes cater for a population of over 400,000 people in the UK, a number which is set to increase as the population ages. The rising demand, combined with the reduction in funding for adult social care, will increase the challenges faced by care homes. The adoption of technology is seen as a way of helping them provide high quality care to their residents and a means of reducing the time spend by care home workers completing paperwork.
One issue faced by care homes is the ability to keep track of how much residents drink each day, to ensure that they don’t become dehydrated. The first Elaros product to be launched through Arquella’s platform will be the hydration monitoring system, Hydr8.
SHEFFIELD (8th April, 2019). Elaros has won funding from Innovate UK to further the development of its innovative digital bladder diary. The bladder diary is a hand-held device designed to help the growing number of men and women in the UK that suffer from bladder problems.
This project will place the bladder diary in specialist continence clinics and GP practices to compare the use of the diary with current practice, paper-based diaries. ‘Real world’ data will be collected which will help to fully evaluate the clinical and health economic impact of the diary.
Elaros CEO, Professor Paul O’Brien remarked, “This funding will enable Elaros and its partners, to carry-out the work that will enable the final adoption of the diary into general practice, which will reduce the unnecessary, inappropriate and very costly referrals to hospital from GPs”. The diary is registered as a Class 1 medical device and has been evaluated by NICE.
Professor O’Brien added, “Receiving funding from Innovate UK to further the development of the diary is extremely significant for the company and we are looking forward to working with our partners, Glasgow Caledonian University and the York Health Economic Forum to carry-out the work” The project will run for one year from 1st July 2019.
SHEFFIELD (25th February, 2019). Elaros is one of 24 companies selected to pitch at the Entrepreneurs of the North competition in London.
The competition, now in its third year, brings the best of the North’s entrepreneurs together with active investors based in the South. On 5th March 2019, 24 Northern businesses will showcase their disruptive products and services in a series of short pitches at NatWest’s iconic London base at 250 Bishopsgate.
Elaros CEO, Professor Paul O’Brien, said, “Elaros is delighted to have been selected. We are looking forward to this opportunity, to set out our story so far, and to talk about our ambitious plans for the company over the next 24 months”
Entrepreneurs of the North is organised by the Innovation SuperNetwork in partnership with the UK Business Angels Association (UKBAA) and British Business Bank. The objective in running this event is to showcase the quality and variety of investment opportunities that exist in the North of England; encouraging out of region investors to invest and co-invest in the North by connecting them to the networks that can make this process easier. The majority of the audience will be active investors, ranging from individual angels to large Venture Capital and Private Equity funds. The remainder will be supporting organisations representing the three Northern regions, British Business Bank and UKBAA.
SHEFFIELD (6th February 2019). Elaros is pleased to announce its sponsorship of a Ph.D studentship in collaboration with the University of Sheffield, the Sheffield Pulmonary Vascular Disease Unit and Sheffield Children’s Hospital. Professor Paul O’Brien CEO of Elaros remarked, “We are delighted to be providing sponsorship for this studentship which will help identify new designs for more effective asthma spacers”
Asthma affects 5.4 million people in the UK alone and is managed by administration of medication via an inhaler, often in combination with an asthma spacer device. Currently, asthma spacers are cumbersome and difficult to use, especially for children, so it hoped that the new project will lead to the design of more effective, portable devices that are easier to use. The project will be supervised by Professor Jim Wild and Dr Alberto Marzo and the work will be carried out at the Insigneo Institute for in-silico medicine, at the University of Sheffield.
Clinical support for this project will be provided by our colleagues from Sheffield Children's NHS Foundation Trust. Prospective candidates will be interviewed on Thursday 14th February 2019. Elaros will be pleased to welcome the new candidate to the project
SHEFFIELD (31st January 2019). Students at Sheffield Hallam University built an additional module to one of Elaros’ digital heath products during the University’s annual ‘scrum week’. Scrum week is designed to give second year Software Engineers and Computer Scientists the chance to get involved in solving real world client problems, including agreeing to sign non-disclosure agreements should they be working on commercially sensitive material. This year, Elaros was one of ten organisations that took part. Following on from briefing events with individual clients, nineteen groups of students worked from 9am to 5pm from 14th January to 18th January, then demonstrated their solutions to their clients.
Paul O’Brien and Claire Horton from Elaros were very impressed with the solutions developed by their teams. Paul O’Brien, CEO of Elaros remarked, “This is exactly what we hoped for. We would like to congratulate both teams for providing Elaros with code that can be combined and used in our existing system”. Elaros wish both teams good luck in their future studies and look forward to participating in next year’s scrum week.
For an informative and informal view from the organiser, Martin Cooper, Senior Lecturer in the Department of Computing, follow the link here
SHEFFIELD (June 1st 2018) – Elaros has recently completed a six-month project looking at how digital technology could be used to help deliver care to people living in care homes.
The project, funded for six months by Innovate UK, aimed to identify the factors that should be considered when developing user-friendly technology to help care home staff support the management of the health and wellbeing of their residents.
During the project, researchers from iCARHO spoke to care home staff from Care Home Assistants to Managers, to learn more about current working practices for recording the health and well-being of residents and the attitudes of staff to the introduction of digital technology to help them in their day to day activities.
Prof Paul O’Brien, Chief Executive of Elaros commented “we found that none of the staff interviewed used any form of mobile or digital technology in their day to day activities and that records of health and wellbeing, for example what residents eat and drink, were recorded on paper”.
Researchers found that even the use of personal computers was limited and that attitudes to the use of digital technology by care home staff were wide ranging from very negative to positive, especially if digital technology could help reduce paperwork. Staff in care homes are aware that “technology is coming” and that it may be not be able to be escaped.
Benefits to moving from paper-based systems to digital systems include, reduction in paperwork, rapid retrieval of information for care homes staff and care home inspectors and the provision of more ‘joined up’ healthcare between care homes and other areas of health service provision. When developing technology for care homes, it should be easy to use, robust and low cost. Frugal innovations that could be added to and rolled-out across a care home group were seen as the way forward.
The funding also enabled Elaros and the partners of the iCARHO project to work with a team of dysphagia experts from Sheffield Teaching Hospitals on the development of a digital Care Home Guide to Dysphagia, a condition that affects the ability of many elderly people to eat and drink safely. The Care Home Guide is currently under further development and will be a resource for staff working at care homes, from caterers and care assistants to managers and policy makers.
Ben Griffin, Lead Specialist for Design at Innovate UK remarked, “Elaros won funding through Innovate UK's Design Foundations competition, enabling them to carry out rigorous customer research and to collaborate with UK design and user testing experts from the earliest stages of the iCARHO project. By using an iterative, human-centred design process, Elaros have developed an adaptable, fit-for-purpose digital platform with a well-considered user experience”.
There are thousands of care homes in the UK catering to an increasing population of elderly residents, each with complex needs. The challenges faced by care homes will continue to grow and the use of digital technology could be a means for helping care homes provide high quality care to their residents.
SHEFFIELD (December 10th 2016) – Elaros Ltd is working in partnership with The Children’s Sleep Charity a national award winning charity based in Yorkshire and Sheffield Children’s Hospital on a pioneering approach to support self-management and clinical decision making in primary care, aligned to better utilisation of limited resources in secondary care. Building upon existing technology the team are creating an app designed to take the young person on a journey that will either help resolve their sleep challenge, where this is linked to lifestyle or point to more challenging sleep disorders (and evidence this) where specialist intervention is required.
Already enjoying success, the project has become among nine chosen to share a total of £900,000 funding as a result of the latest Small Business Research Initiative for Healthcare (SBRI Healthcare) competition.
This competition was delivered in partnership by the Yorkshire & Humber Academic Health Science Network (AHSN) and the Technology Innovation Transforming Child Health (TITCH) Network on behalf of SBRI Healthcare, an NHS England initiative led by the country’s 15 Academic Health Science Networks.
With six percent of children in the UK living with disability, ingenious life changing solutions can ensure they have the best start in life. The technologies recognise the importance of encouraging independence and focus on restoring function and providing appropriate support for self-care and remote monitoring.
Prof Paul O’Brien, Chief Executive of Elaros, commented “The Board and staff of Elaros are delighted to have won this prestigious competition, which comes as the company starts to develop other products to address unmet clinical needs in areas that have not yet seen the application of the power of digital health. “We are excited to be embarking upon this important project with our partners at Sheffield Children's NHS Foundation Trust, the Children's Sleep Charity and Dr Michael Boyle and believe that our proposed solution will make a significant difference to the lives of families blighted by sleep difficulties. Through the empowerment of families, the Sleep Diary Partnership, led by Elaros, believes that significant saving will be achieved for the NHS through the deployment of our digital solution that will be free at the point of use."
Vicki Dawson of The Children’s Sleep Charity says “We are delighted to be working at the forefront of development to ensure that new technology can support and help families of children with sleep issues. With up to 80% of children with additional needs suffering some form of sleep issue, making the assessment and diagnosis as simple and uninvasive as possible is vital.”
Philippa Hedley-Takhar, Head of Investment & Partnerships for Yorkshire & Humber AHSN commented: “Children and young people with long term conditions spend much of their childhood in healthcare environments. This competition was designed to stimulate development of solutions to improve quality of life, promote independence and individual empowerment identified as a much- needed area of focus from families, young people and clinicians.”
SHEFFIELD (20 June 2016) - Elaros is very pleased to be able to announce that Dr Sue Smith from the University of Sheffield has joined the Company on secondment as New Opportunities Manager. Sue's focus with Elaros will be to support the Company's work with pharma companies by identifying and delivering opportunities through, for example, their open innovation schemes.
Sue joins Elaros under the University of Sheffield's Pilot MRC Proximity to Discovery (P2D): Industry Engagement Scheme.
Sue manages the Sheffield Healthcare Gateway in the Faculty of Medicine, Dentistry and Health and the small team of business managers developing translational, commercial and knowledge exchange projects with industry. Before taking up her position, Sue spent five years as a Research Translator in the Department of Biomedical Science, Sheffield, and has 7 years experience working in biotech firms in Germany and the US.
Sue has a PhD from the European Molecular Biology Laboratory in Heidelberg and a BA (Hons) in Biochemistry from Oxford University.
Sue's specialties are: IP identification and development, business development, R&D and translational funding (MRC DPFS, MRC Confidence in Concept, Biomedical Catalyst, Wellcome Trust i4i, Wellcome Trust/Dept of Health - Health Innovation Challenge Fund), grant and proposal writing, project management, collaboration and relationship building, and facilitating knowledge exchange between academic and commercial sectors.
Professor Paul O’Brien, CEO of Elaros, said “I am delighted to be able to welcome Sue to the Team and I look forward to working with Sue over the coming months. Sue's arrival at Elaros represents an important development in the Company's excellent relationship with the University of Sheffield”.
Dr Sue Smith said “I am very pleased to have this excellent opportunity to work with Elaros in a start-up environment involved in digital healthcare. It will be exciting to identify and develop new opportunities for the Company”.
SHEFFIELD (March 10th 2016) - Professor Paul O’Brien, Elaros’ CEO, took part in the recent Northern Powerhouse Trade Mission to Beijing, China.
The technology-focused mission was geared to high growth companies keen to make contacts and create business opportunities in developing Chinese sectors, in Elaros’ case in Medical & Consumer Health Products.
Organised by RTC North and UK Trade & Investment, the Trade Mission was supported in China by Coway International, the commercial company for Tsinghua which is widely regarded as the country’s top research university. Coway facilitated business meetings, sourcing market information, and demonstrations of Chinese research and development, as well as introductions to local and national technology clusters such as China Technology Exchange Co Ltd, Zhongguancun Medical Devices Innovation Alliance and Peking University Care Industrial Park.
Prof O’Brien said “The mission was hugely valuable in making key healthcare connections in China, that otherwise would have been much more time-consuming to make. Our group was very impressed by the scale and ambition of Chinese plans in the medical sector, which provide a significant opportunity for Elaros”.
SHEFFIELD (February 8th 2016) - Elaros has been awarded £5,000 from Innovate UK for a cyber security project with the University of Bradford. Funded through the Innovation Voucher scheme, the project focuses on how Elaros can best protect their customer data.
Innovate UK Innovation Vouchers provide funding to support businesses in working with external experts to gain additional knowledge to innovate and grow. This particular voucher is for cyber security advice to help protect businesses from cyber crime and hacking.
Dr Angel Jimenez-Aranda, Technology Development Manager at Elaros, said “Our collaboration with the universities allows us to fully explore this area to ensure our technology platform is as well protected and secure as possible. The arrangement is ideal because the university teams bring extensive experience in computing and cyber security that augments our strong internal capability”.
SHEFFIELD (January 20th 2016) - Elaros 24/7 Limited, a provider of innovative digital health solutions for the management and monitoring of people with long-term conditions, has closed its second investment round with £584,000 to take the business forward in 2016.
The investment is made up of £100,000 from the Big Venture Challenge, £450,000 raised from private investors and £34,000 from Creative England. Managed by UnLtd, the Big Venture Challenge supports entrepreneurial individuals and organisations to deliver social impact at scale, and as part of its remit, Creative England backs SMEs to develop innovative digital health products and services for the health and social care market.
The funds will support the completion of pilot studies of the Elaros Digital Bladder Diary within the NHS in Sheffield and the North-East of England and the further refinement of the service for a subsequent roll out. They will also underpin the development of new product concepts in the Elaros portfolio.
Professor Paul O’Brien, CEO of Elaros, said “We are delighted to announce this key milestone for Elaros. This investment will allow us to continue making great strides in bringing our health self-management solutions to market and securing contracts with the NHS”.
SHEFFIELD (April 24th 2015) - ELAROS 24/7 Ltd, a leading provider of clinical decision tools for the triage, diagnose and management of Lower Urinary Tract Symptoms, has participated in the 4th NWC Connected Health Ecosystem event.
The event took place on the 23rd April 2013 at the Langtree Park Stadium in St Helens (Merseyside, United Kingdom) and had a strong clinical voice, providing delegates with an opportunity to present latest digital products aimed at empowering patients to manage their own health and care. The event was organised by the North West Coast Academic Health Science Network in partnership with the European Connected Health Alliance.
‘Treatment and care of those with long-term conditions accounts for 70 per cent of the primary and acute care budget in England. Our company provides a patient-centred service that integrates and enhances the delivery of the patient pathway, enables compliance with NICE guidelines and reduces appointment and diagnostic costs” said ELAROS Chief Executive Officer, Paul O’Brien. The 4th NWC Connected Health Ecosystem event was a great opportunity to demonstrate how the new version of the ELAROS system enhances patient experience and facilitates the clinical decision.
The North West Coast Academic Health Science Network (NWC AHSN) is one of 15 AHSNs established by the NHS in England during 2013–14. NWC AHSN covers a population of 4 million residents in Cheshire, Merseyside, South Cumbria and Lancashire.
The Networks are a product of the Government’s Innovation, Health and Wealth strategy. Their primary role is to form a network of NHS organisations, universities and businesses and achieve measurable results in key delivery areas.
AHSNs ensure that innovation is spread at “scale and pace” with consequent benefits for the health and wealth of individuals, communities, regions and the nation.
SURREY (May 30th 2014) - ELAROS 24/7 Ltd participates in the workshop Entrepreneurial University, Engaged Industry & Active Government: Triple Helix Opportunities, hosted by the University of Surrey.
SHEFFIELD (May 20th 2014) – ELAROS 24/7, an innovative new service that improves the initial assessment, diagnosis and triaging of patients with lower urinary tract symptoms (LUTS), has secured £96,000 of funding from the Academic Health Health Science Network for the North East and North Cumbria (AHSN NENC).
Of 139 applications submitted to the AHSN NENC, ELAROS 24/7 was one of 45 projects that shared the £3,000,000 of funding.
ELAROS 24/7 has created a hand-held electronic bladder diary (the size of a smart phone) (UroDiary®) that captures patient data and an uploader that is deployed to clinicians' desktop computers (UroUpload™) that extracts data from the UroDiary and transfers the information to an algorithm (UroConnect®) that sits on NHS system (N3). The algorithm provides immediate, accurate, simple and intuitive clinical direction.
At a Stakeholder Event organised by the AHSN NENC at the Marriot Hotel in Gateshead on the 9 May 2014, ELAROS 24/7 was 1 of 7 projects that was showcased. This well attended event has provided ELAROS 24/7 with the opportunity to engage directly with both providers and commissioners on the ground and the Company is now working with potential partners on designing the roll-out and implementation of the rural pilot.
After the Stakeholder Event, Professor Paul O' Brien, Chief Executive Office of ELAROS 24/7 said: “Winning this strategically important funding for our rural pilot in the North East and North Cumbria enables the Company to engage with new partners on piloting a system that will bring about transformational change to service delivery and greater involvement/control of patients in managing and monitoring their own health.”
SHEFFIELD (December 14th 2013) – ELAROS 24/7, an innovative new service that improves the initial assessment, diagnosis and triaging of patients with Lower Urinary Tract Symptoms (LUTS), has won the Innovative Ageing of the Year Award at the Bionow Annual Awards 2013.
ELAROS 24/7's Deputy Chairman, Martin Levermore MBE collected the award, sponsored by MIMIT / Edwards Healthcare, at Bionow’s Annual Awards Dinner held on the evening of the 28 November 2013 at the Mere Golf Resort & Spa, Cheshire, attended by over 300 executives from across the biomedical sector.
The event, which was hosted by Dr John Stageman OBE, Chair of Bionow and Dr Geoff Davison, CEO of Bionow, showcases the best of business growth, competitiveness and innovation within the biomedical and life science sectors across Northern England.
ELAROS 24/7 has created a hand-held electronic bladder diary (the size of a smart phone) (UroDiary®) that captures patient data and an uploader that is deployed to clinicians' desktop computers (UroUpload™) that extracts data from the UroDiary and transfers the information up to an algorithm (UroConnect®) that sits on NHS system (N3). The algorithm provides immediate, accurate, simple and intuitive clinical direction.
The award comes at the end of year that saw the UroConnect secure CE mark as a medical device and Elaros 24/7 winning the Big Venture Challenge in May 2013.
ELAROS 24/7, based at the Sheffield Digital Campus, was also shortlisted in September 2013 for The Annual Medical Innovation Competition in the Software and Telehealth category.
Professor Paul O' Brien, Chief Executive Office of ELAROS 24/7 said: “Winning this prestigious award caps a great first year for all those involved in and around the company since our market announcement at the NHS Expo at the Excel Centre in London in March 2013.”
SHEFFIELD (December 13th 2012) – The world’s first virtual assessment clinic in the field of Lower Urinary Tract Symptoms (LUTS) has been launched. ELAROS 24/7 is an innovative new way of carrying out initial assessment as well as the long term management and monitoring of patients with LUTS. LUTS refers to a range of urinary problems that can significantly impair the quality of life for sufferers. Effective treatment requires clinical evidence on frequency of urine volumes passed and urgency, which is typically recorded using paper diaries. Use of such diaries is infrequent outside specialist services due to limited experience in primary care and the difficulty of interpreting the raw, variable data.
A potential solution to these problems has been developed by ELAROS 24/7 Ltd (Electronic LUTS And Remote Observation Service). The system, ELAROS 24/7, was launched at a special event at the University of Sheffield’s conferencing facility, The Edge, which was attended by more than 100 clinicians, business people and key stakeholders.
ELAROS 24/7 Ltd is a partnership between Devices for Dignity (D4D)/Sheffield Teaching Hospital Foundation Trust, MDTi Healthcare Ltd, Medipex (NHS Innovation Hub for Yorkshire and Humber) and RTC North, with funding awarded through the Engineering and Physical Science Research Council (EPSRC).
The ELAROS system consists of three parts – the UroDiary (to collect data), the UFlow meter (to measure flow rates) and the UroConnect (to manage and analyse data). Informed by NICE guidelines on the identification and management of LUTS, ELAROS 24/7 is used by the patient to record times, volumes passed, and the desire to urinate. Once recoded, data is downloaded to the GP’s computer system for data visualisation, interpretation and patient management.
The UroDiary®, a portable electronic diary, is more discrete than writing in a diary, and makes data easily traceable and transferable between healthcare providers. Simple data capture, analysis and quicker diagnosis will potentially save the NHS £66M per year* through reduction in referrals to secondary care and diagnostic costs.
Professor Chris Chapple, D4D’s Urinary Continence Management Theme Lead, said at the launch event: “A bladder diary is an essential tool for clinicians assessing lower urinary tract symptoms – but a paper diary is not practical and often not reliable. “ELAROS 24/7 gives the clinician a huge amount of information and allows us to effectively and accurately evaluate and treat people. ” It is also predicted that the ELAROS service will make significant savings on pharmacology budgets of at least 10% on the drugs being used in this area of health, with a pilot being run in February 2013 to test these assumptions.
Paul O’Brien, Chief Executive of ELAROS 24/7 Ltd, said: “ELAROS 24/7 reduces the need for patients to make unnecessaryjourneys to their GP and also cuts down on inappropriate referrals – therefore benefiting both GP and patient, as well as reducing costs for the NHS.”
We aim to keep the information on our website accurate but if errors are brought to our attention we will endeavour to correct them. We reserve the right to withdraw any of the content of this site at any time and we don't accept responsibility for the content of third party websites.
We don't collect Cookies, but if you contact us via our website, your name, e-mail address and your message will be e-mailed to us. We will keep your information private and won't release it to third parties, unless we have your permission to do so.
The information you send us, may be used to keep you informed of Elaros’ developments. If you no longer wish to receive information, please e-mail us on: firstname.lastname@example.org